The Valley Desk

NCT06373731 · Interventional trial

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Overall registry status Active not recruiting

Phase 3

Conditions Age Related Macular Degeneration (ARMD)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov